Literature DB >> 19830739

The antimicrobial activity of CCL28 is dependent on C-terminal positively-charged amino acids.

Bin Liu1, Eric Wilson.   

Abstract

Several chemokines have been shown to act as antimicrobial proteins, suggesting a direct contribution to innate immune protection. Based on the study of defensins and other antimicrobial peptides, it has been proposed that cationic amino acids in these proteins play a key role in their antimicrobial activity. The primary structure requirements necessary for the antimicrobial activity of chemokines, however, have not yet been elucidated. Using mouse CCL28, we have identified a C-terminal region of highly-charged amino acids (RKDRK) that is essential to the antimicrobial activity of the murine chemokine. Additionally, other positively-charged amino acids in the C-terminus of the protein contribute to the observed antimicrobial effect. Charge reversal and deletion mutations support our hypothesis that C-terminal positively-charged amino acids are essential for the antimicrobial activity of CCL28. Results also demonstrate that although the C-terminal region of the chemokine is essential, it is not sufficient for full antimicrobial activity of CCL28.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19830739      PMCID: PMC2866449          DOI: 10.1002/eji.200939819

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  48 in total

1.  Amphipathic alpha helical antimicrobial peptides.

Authors:  A Giangaspero; L Sandri; A Tossi
Journal:  Eur J Biochem       Date:  2001-11

2.  Antimicrobial peptides of multicellular organisms.

Authors:  Michael Zasloff
Journal:  Nature       Date:  2002-01-24       Impact factor: 49.962

3.  CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity.

Authors:  Kunio Hieshima; Haruo Ohtani; Michiko Shibano; Dai Izawa; Takashi Nakayama; Yuri Kawasaki; Fumio Shiba; Mitsuru Shiota; Fuminori Katou; Takuya Saito; Osamu Yoshie
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

Review 4.  Mode of action of membrane active antimicrobial peptides.

Authors:  Yechiel Shai
Journal:  Biopolymers       Date:  2002       Impact factor: 2.505

Review 5.  Role of chemokines in the pathogenesis of asthma.

Authors:  N W Lukacs
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

6.  The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus.

Authors:  David J Schibli; Howard N Hunter; Vladimir Aseyev; Timothy D Starner; John M Wiencek; Paul B McCray; Brian F Tack; Hans J Vogel
Journal:  J Biol Chem       Date:  2001-12-11       Impact factor: 5.157

7.  Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC).

Authors:  B Homey; W Wang; H Soto; M E Buchanan; A Wiesenborn; D Catron; A Müller; T K McClanahan; M C Dieu-Nosjean; R Orozco; T Ruzicka; P Lehmann; E Oldham; A Zlotnik
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

8.  Structural diversity of heparan sulfate binding domains in chemokines.

Authors:  Hugues Lortat-Jacob; Aurélien Grosdidier; Anne Imberty
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

9.  The structure of human macrophage inflammatory protein-3alpha /CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins.

Authors:  David M Hoover; Cyril Boulegue; De Yang; Joost J Oppenheim; Kenneth Tucker; Wuyuan Lu; Jacek Lubkowski
Journal:  J Biol Chem       Date:  2002-07-30       Impact factor: 5.157

10.  The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane-disrupting properties and is antibacterial.

Authors:  Helena M Linge; Mattias Collin; Pontus Nordenfelt; Matthias Mörgelin; Martin Malmsten; Arne Egesten
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

View more
  22 in total

Review 1.  CCR10 and its ligands in regulation of epithelial immunity and diseases.

Authors:  Na Xiong; Yaoyao Fu; Shaomin Hu; Mingcan Xia; Jie Yang
Journal:  Protein Cell       Date:  2012-06-08       Impact factor: 14.870

2.  Induction of Interleukin 10 by Borrelia burgdorferi Is Regulated by the Action of CD14-Dependent p38 Mitogen-Activated Protein Kinase and cAMP-Mediated Chromatin Remodeling.

Authors:  Bikash Sahay; Kathleen Bashant; Nicole L J Nelson; Rebeca L Patsey; Shiva Kumar Gadila; Rebecca Boohaker; Ashutosh Verma; Klemen Strle; Timothy J Sellati
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

3.  Chemokine ligand 28 (CCL28) negatively regulates trabecular bone mass by suppressing osteoblast and osteoclast activities.

Authors:  Rina Iwamoto; Takumi Takahashi; Kazuto Yoshimi; Yuji Imai; Tsuyoshi Koide; Miroku Hara; Tadashi Ninomiya; Hiroaki Nakamura; Kazutoshi Sayama; Akira Yukita
Journal:  J Bone Miner Metab       Date:  2021-03-15       Impact factor: 2.626

4.  Identification of the bacterial protein FtsX as a unique target of chemokine-mediated antimicrobial activity against Bacillus anthracis.

Authors:  Matthew A Crawford; David E Lowe; Debra J Fisher; Scott Stibitz; Roger D Plaut; John W Beaber; Jason Zemansky; Borna Mehrad; Ian J Glomski; Robert M Strieter; Molly A Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

5.  CXCL17 is a mucosal chemokine elevated in idiopathic pulmonary fibrosis that exhibits broad antimicrobial activity.

Authors:  Amanda M Burkhardt; Kenneth P Tai; Juan P Flores-Guiterrez; Natalia Vilches-Cisneros; Karishma Kamdar; Oralia Barbosa-Quintana; Ricardo Valle-Rios; Peter A Hevezi; Joaquin Zuñiga; Moises Selman; André J Ouellette; Albert Zlotnik
Journal:  J Immunol       Date:  2012-05-18       Impact factor: 5.422

6.  A Requirement for Metamorphic Interconversion in the Antimicrobial Activity of Chemokine XCL1.

Authors:  Amanda M Nevins; Akshay Subramanian; Jazma L Tapia; David P Delgado; Robert C Tyler; Davin R Jensen; André J Ouellette; Brian F Volkman
Journal:  Biochemistry       Date:  2016-06-28       Impact factor: 3.162

7.  The Solution Structure of CCL28 Reveals Structural Lability that Does Not Constrain Antifungal Activity.

Authors:  Monica A Thomas; Jie He; Francis C Peterson; Anna R Huppler; Brian F Volkman
Journal:  J Mol Biol       Date:  2018-06-15       Impact factor: 5.469

8.  Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.

Authors:  Paulus H S Kwakman; Jeroen Krijgsveld; Leonie de Boer; Leonard T Nguyen; Laura Boszhard; Jocelyne Vreede; Henk L Dekker; Dave Speijer; Jan W Drijfhout; Anje A te Velde; Wim Crielaard; Hans J Vogel; Christina M J E Vandenbroucke-Grauls; Sebastian A J Zaat
Journal:  J Biol Chem       Date:  2011-10-24       Impact factor: 5.157

9.  Exploring platelet chemokine antimicrobial activity: nuclear magnetic resonance backbone dynamics of NAP-2 and TC-1.

Authors:  Leonard T Nguyen; Paulus H S Kwakman; David I Chan; Zhihong Liu; Leonie de Boer; Sebastian A J Zaat; Hans J Vogel
Journal:  Antimicrob Agents Chemother       Date:  2011-02-14       Impact factor: 5.191

10.  Comparison of cytokine expressions in acute myocardial infarction and stable angina stages of coronary artery disease.

Authors:  Wenwen Yan; Siwan Wen; Lemin Wang; Qianglin Duan; Lin Ding
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.